155 related articles for article (PubMed ID: 34745986)
21. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
[TBL] [Abstract][Full Text] [Related]
22. The impact of geriatric nutritional risk index on surgical outcomes after esophagectomy in patients with esophageal cancer.
Kubo N; Sakurai K; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Yashiro M; Ohira M
Esophagus; 2019 Apr; 16(2):147-154. PubMed ID: 30311102
[TBL] [Abstract][Full Text] [Related]
23. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
24. Is there association of gross tumor volume of adenocarcinoma of oesophagogastric junction measured on magnetic resonance imaging with N stage?
Jiang Y; Chen YL; Chen TW; Wu L; Ou J; Li R; Zhang XM; Yang JQ; Cao JM
Eur J Radiol; 2019 Jan; 110():181-186. PubMed ID: 30599858
[TBL] [Abstract][Full Text] [Related]
25. Gross tumor volume is the prognostic factor for squamous cell esophageal cancer patients treated with definitive radiotherapy.
Chen Y; Zhang Z; Jiang G; Zhao K
J Thorac Dis; 2016 Jun; 8(6):1155-61. PubMed ID: 27293832
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic factors associated with pathologic upstaging in patients clinically diagnosed stage T2N0M0 squamous cell esophageal carcinoma.
Li M; Xie H; Zhen F; Wang H; Peng Z; Xu L
J Cancer Res Ther; 2020 Sep; 16(5):1106-1111. PubMed ID: 33004755
[TBL] [Abstract][Full Text] [Related]
27. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
[TBL] [Abstract][Full Text] [Related]
28. The preoperative hemoglobin, albumin, lymphocyte and platelet (HALP) score is a useful predictor in patients with resectable esophageal squamous cell carcinoma.
Feng JF; Wang L; Yang X
Bosn J Basic Med Sci; 2021 Dec; 21(6):773-781. PubMed ID: 33974528
[TBL] [Abstract][Full Text] [Related]
29. CT radiomics features to predict lymph node metastasis in advanced esophageal squamous cell carcinoma and to discriminate between regional and non-regional lymph node metastasis: a case control study.
Ou J; Wu L; Li R; Wu CQ; Liu J; Chen TW; Zhang XM; Tang S; Wu YP; Yang LQ; Tan BG; Lu FL
Quant Imaging Med Surg; 2021 Feb; 11(2):628-640. PubMed ID: 33532263
[TBL] [Abstract][Full Text] [Related]
30. [Predictive value of log odds of positive lymph nodes for the prognosis of patients with node-negative squamous cell carcinoma of the thoracic esophagus after radical esophagectomy].
Yang M; Zhang H; Huo X; Chen C; Yu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):535-9. PubMed ID: 27215521
[TBL] [Abstract][Full Text] [Related]
31. Endoscopic resection as an independent predictive factor of local control in patients with T1bN0M0 esophageal squamous cell carcinoma treated with chemoradiotherapy: a retrospective study.
Miyazaki T; Myojin M; Hosokawa M; Aoyama H; Okahara S; Takahashi H
Radiat Oncol; 2022 Jan; 17(1):11. PubMed ID: 35057830
[TBL] [Abstract][Full Text] [Related]
32. CT radiomic features for predicting resectability of oesophageal squamous cell carcinoma as given by feature analysis: a case control study.
Ou J; Li R; Zeng R; Wu CQ; Chen Y; Chen TW; Zhang XM; Wu L; Jiang Y; Yang JQ; Cao JM; Tang S; Tang MJ; Hu J
Cancer Imaging; 2019 Oct; 19(1):66. PubMed ID: 31619297
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment NRS-2002 scores combined with hematologic inflammation markers are independent prognostic factors in patients with resectable thoracic esophageal squamous cell carcinoma.
Guo XW; Liu YC; Gao F; Ji SJ; Zhou JY; Ji L; Zhou SB
Cancer Manag Res; 2018; 10():2409-2418. PubMed ID: 30122990
[TBL] [Abstract][Full Text] [Related]
34. Tumor Size at Magnetic Resonance Imaging Association With Lymph Node Metastasis and Lymphovascular Space Invasion in Resectable Cervical Cancer: A Multicenter Evaluation of Surgical Specimens.
Chen XL; Chen GW; Xu GH; Ren J; Li ZL; Pu H; Li H
Int J Gynecol Cancer; 2018 Oct; 28(8):1545-1552. PubMed ID: 30044321
[TBL] [Abstract][Full Text] [Related]
35. Texture analysis of CT imaging for assessment of esophageal squamous cancer aggressiveness.
Liu S; Zheng H; Pan X; Chen L; Shi M; Guan Y; Ge Y; He J; Zhou Z
J Thorac Dis; 2017 Nov; 9(11):4724-4732. PubMed ID: 29268543
[TBL] [Abstract][Full Text] [Related]
36. The Blood Oxygenation T
Tang YL; Zhang XM; Yang ZG; Huang YC; Chen TW; Chen YL; Chen F; Zeng NL; Li R; Hu J
Korean J Radiol; 2017; 18(4):674-681. PubMed ID: 28670162
[TBL] [Abstract][Full Text] [Related]
37. Computed tomography-based radiomic analysis for prediction of treatment response to salvage chemoradiotherapy for locoregional lymph node recurrence after curative esophagectomy.
Gu L; Liu Y; Guo X; Tian Y; Ye H; Zhou S; Gao F
J Appl Clin Med Phys; 2021 Nov; 22(11):71-79. PubMed ID: 34614265
[TBL] [Abstract][Full Text] [Related]
38. Computed Tomography-Based Radiomics in Predicting T Stage and Length of Esophageal Squamous Cell Carcinoma.
Yang M; Hu P; Li M; Ding R; Wang Y; Pan S; Kang M; Kong W; Du D; Wang F
Front Oncol; 2021; 11():722961. PubMed ID: 34722265
[TBL] [Abstract][Full Text] [Related]
39. Significance of intratreatment tumor volume change during chemoradiotherapy for potentially resectable thoracic esophageal squamous cell carcinoma.
Li D; Zhang Q; Yang Y; Yin H; Zhu C; Li X
Am J Transl Res; 2022; 14(7):4776-4785. PubMed ID: 35958444
[TBL] [Abstract][Full Text] [Related]
40. Gross Tumor Volume Definition and Comparative Assessment for Esophageal Squamous Cell Carcinoma From 3D
Yue Y; Li N; Shahid H; Bi D; Liu X; Song S; Ta D
Front Oncol; 2022; 12():799207. PubMed ID: 35372054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
